Fluorescent hyper-cross-linked β-cyclodextrin-carbon quantum dot (β-CD-CQD) hybrid nanosponges of about 200 nm with excellent biocompatibility and strong bright blue fluorescence excited at 365 nm with a high photoluminescence quantum yield (PLQY) of 38.0% were synthesized for tumor theranostic application by facile condensation polymerization of carbon quantum dots (CQDs) with β-cyclodextrin (β-CD) at a feeding ratio of 1:5. The DOX@β-CD-CQD theranostic nanomedicine, around 300 nm with DOX-loading capacity of 39.5% by loading doxorubicin (DOX) via host-guest complexation, showed a pH responsive controlled release and released DOX in the simulated tumor microenvironment in a sustained release mode, owing to the formation constant in the supramolecular complexation of DOX with the β-CD units in the β-CD-CQD nanosponges. The proposed DOX@β-CD-CQD theranostic nanomedicine could be internalized into HepG2 cells, and the released DOX was accumulated into the cell nuclei, demonstrating an antitumor efficacy more enhanced than that of the free drug.

No abstract

No abstract

Electrospun polyimide (PI) separators were found to reduce the charge‐transfer resistance of Li plating/stripping and the overpotentials of Li nucleation/growth onto Cu foils in the 1.2 M LiPF6/(ethylene carbonate/dimethyl carbonate = 1/1) electrolyte without any additives in comparison with polyethylene (PE) separators. Lithium deposition through the PI separator led to the formation of a granular morphology of 15–30 µm in diameter compared to lithium dendrites using PE. A similar trend of lithium deposition was observed in LiFePO4//Cu cells. The PI separator was found to enhance the discharge capacity and cycle life of Li plating/stripping in the Li//Cu and LiFePO4//Cu cells containing 40 µl electrolytes, verifying that the PI separator provides dendrite inhibition capability for the lithium‐metal‐free cells.